Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 164

Related Citations for PubMed (Select 16775338)


Alternative fates of keratinocytes transduced by human papillomavirus type 18 E7 during squamous differentiation.

Chien WM, Noya F, Benedict-Hamilton HM, Broker TR, Chow LT.

J Virol. 2002 Mar;76(6):2964-72.


Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes.

Genovese NJ, Banerjee NS, Broker TR, Chow LT.

J Virol. 2008 May;82(10):4862-73. doi: 10.1128/JVI.01202-07. Epub 2008 Mar 5.


Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entry.

Chien WM, Parker JN, Schmidt-Grimminger DC, Broker TR, Chow LT.

Cell Growth Differ. 2000 Aug;11(8):425-35.


Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes.

Banerjee NS, Wang HK, Broker TR, Chow LT.

J Biol Chem. 2011 Apr 29;286(17):15473-82. doi: 10.1074/jbc.M110.197574. Epub 2011 Feb 14.


The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle.

Flores ER, Allen-Hoffmann BL, Lee D, Lambert PF.

J Virol. 2000 Jul;74(14):6622-31.


Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes.

Wang HK, Duffy AA, Broker TR, Chow LT.

Genes Dev. 2009 Jan 15;23(2):181-94. doi: 10.1101/gad.1735109. Epub 2009 Jan 8.


HPV-16 E7 protein bypasses keratinocyte growth inhibition by serum and calcium.

Pei XF, Sherman L, Sun YH, Schlegel R.

Carcinogenesis. 1998 Aug;19(8):1481-6.


Protein profiling and identification of modulators regulated by human papillomavirus 16 E7 oncogene in HaCaT keratinocytes by proteomics.

Lee KA, Kang JW, Shim JH, Kho CW, Park SG, Lee HG, Paik SG, Lim JS, Yoon DY.

Gynecol Oncol. 2005 Oct;99(1):142-52.


miR-24 and miR-205 expression is dependent on HPV onco-protein expression in keratinocytes.

McKenna DJ, Patel D, McCance DJ.

Virology. 2014 Jan 5;448:210-6. doi: 10.1016/j.virol.2013.10.014. Epub 2013 Oct 29.


The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation.

Zhang B, Chen W, Roman A.

Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):437-42. Epub 2005 Dec 28.


Nonconserved lysine residues attenuate the biological function of the low-risk human papillomavirus E7 protein.

Genovese NJ, Broker TR, Chow LT.

J Virol. 2011 Jun;85(11):5546-54. doi: 10.1128/JVI.02166-10. Epub 2011 Mar 16.


Activation of Src, Fyn and Yes non-receptor tyrosine kinases in keratinocytes expressing human papillomavirus (HPV) type 16 E7 oncoprotein.

Szalmás A, Gyöngyösi E, Ferenczi A, László B, Karosi T, Csomor P, Gergely L, Veress G, Kónya J.

Virol J. 2013 Mar 7;10:79. doi: 10.1186/1743-422X-10-79.


Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.

Nees M, Geoghegan JM, Munson P, Prabhu V, Liu Y, Androphy E, Woodworth CD.

Cancer Res. 2000 Aug 1;60(15):4289-98.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk